Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2010
03/24/2010CN101675918A Self-emulsifying micro-emulsion composition, preparation method and usage thereof
03/24/2010CN101675916A Preparation method of levo-ofloxacin hyaluronic acid gel slow-released agent
03/24/2010CN100595281C Adenocarcinoma marker and its uses
03/24/2010CN100595218C Method for preparing amphophilic amphoteric ion polymer and pH response type polymer micelle buffer solution thereof
03/24/2010CN100594941C Method for the preparation of molecular complexes
03/24/2010CN100594940C Supermolecule water soluble freeze drying matter of indissoluble medicament and method of preparing the same
03/24/2010CN100594939C Medicament sustained-release carrier for eyes with cooperation treatment function
03/24/2010CN100594938C Pulullan polysaccharide carrier material having the function of targeting therapy of cancer
03/24/2010CN100594937C Stable injection composition and method therefor
03/24/2010CN100594936C Method of enhancing absorptions of transmucosal administration formulations
03/24/2010CN100594929C Oral insulin medicine and preparation method thereof
03/24/2010CN100594912C Preparation of beauty gel for treating acne and preparing method
03/24/2010CN100594908C Triamcinolone benetonide local film forming gel composition
03/24/2010CN100594907C Pharmaceutical formulation for contraception and hormone-replacement therapy
03/24/2010CN100594905C Benazepril pharmaceutical compsition and process for its preparation
03/24/2010CN100594901C Aqueous ophthalmic suspension of crystalline rebamipide
03/24/2010CN100594898C Pharmaceutical composition of Silybin and preparation method thereof
03/24/2010CN100594897C Cannabinoid liquid formulations for mucosal amdinistration
03/24/2010CN100594894C New formulation for retinoid-containing soft gelatin capsules
03/24/2010CN100594893C Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
03/24/2010CN100594889C Penciclovir freeze dried and method of manufacturing the same
03/24/2010CN100594888C Pharmaceutical compositions suitable for the treatment of ophthalmic diseases
03/24/2010CN100594887C Anticancer slow release injection comprising tetrazole violet and potentiating agent thereof
03/24/2010CN100594886C Anticancer slow release agent loading both newborn blood vessel and tetrazole violet
03/24/2010CN100594884C Recombination human interferon injection
03/23/2010US7684852 System, formulation, kit and method for tagging colonic residue in an individual
03/23/2010US7683039 Water soluble, randomly substituted partial N-, partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
03/23/2010US7683038 Such as gellan, carboxymethylcellulose, pectic acid, pectin and hyaluronic acid derivativesl; for use in the pharmaceutical, biomedical, surgical and healthcare fields
03/23/2010US7683030 Methods of treating diabetes with albumin-conjugated exendin peptides
03/23/2010US7683024 Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications
03/23/2010US7682635 Aqueous dispersions of nanometric or micrometric particles for encapsulating chemical compounds
03/23/2010US7682632 Tamper-resistant oral opioid agonist formulations
03/23/2010US7682630 Antitumor agent that forms polymeric micelle complex of low molecule weight antitumor agent with styrene maleic acid copolymer; formed in polymeric micelle complex by intermolecular bonding or mutual interaction between styrene maleic acid copolymer and antitumor agent; reduced side effects
03/23/2010US7682626 Polyvinylethers for delivery of polynucleotides to mammalian cells
03/23/2010US7682625 Comprising hydrolyzed gelatin/tryptophan and ingestible carrier; for decubitus ulcers/bariatric surgery
03/23/2010US7682624 Method for treating wounds to promote healing
03/23/2010US7682623 Pharmaceutical composition for topical application
03/23/2010US7682620 Oil-containing biliquid foam dispersed in a salt-containing aqueous phase having a pH of less than about 7, is gelled by a polymeric sulfonic acid, e.g., ammonium acrylamidopropanesulfonic acid-vinylformamide copolymer
03/23/2010US7682608 Stabilized preparations containing antibody
03/23/2010US7682606 Methods of producing edible fungi containing activated folates and nutritional supplements containing activated folates
03/23/2010US7682387 Drug-delivery endovascular stent and method for treating restenosis
03/23/2010CA2607237C The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
03/23/2010CA2424656C Composition and method for stable injectable liquids
03/23/2010CA2421240C Granular preparations for oral administration
03/23/2010CA2408992C Pharmaceutical preparation for the diagnosis of helicobacter pylori infection
03/23/2010CA2407261C Confectionery product containing functional ingredients
03/23/2010CA2406533C 3-methoxybenzyl thiourea derivatives and lipid composition containing same
03/23/2010CA2399405C 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents
03/23/2010CA2396702C N,o-amidomalonate platinum complexes
03/23/2010CA2389251C Swelling and deswelling polymer blends
03/23/2010CA2380951C Pharmaceutical compositions for oral and topical administration
03/23/2010CA2377783C Epitopes formed by non-covalent association of conjugates
03/23/2010CA2377278C Prodrugs of carbamate inhibitors of impdh
03/23/2010CA2372994C Implantable gel compositions and method of manufacture
03/23/2010CA2329000C Stabilised virus preparation
03/23/2010CA2325386C Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
03/23/2010CA2197982C Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
03/23/2010CA2194797C Nucleic acid containing composition, preparation and uses of same
03/23/2010CA2176927C Transparent liquid for encapsulated drug delivery
03/23/2010CA2172906C Biocompatible adhesive compositions
03/18/2010WO2010030995A2 Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
03/18/2010WO2010030821A2 Ibuprofen for topical administration
03/18/2010WO2010030739A1 Polyethylene glycol lipid conjugates and uses thereof
03/18/2010WO2010030730A1 Polyethylene glycol lipid conjugates and uses thereof
03/18/2010WO2010030670A2 Compositions and methods for the prevention of oxidative degradation of proteins
03/18/2010WO2010030598A2 Pharmaceutical formulations comprising pemetrexed
03/18/2010WO2010030366A2 Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method
03/18/2010WO2010030342A2 Heparosan polymers and methods of making and using same for the enhancement of therapeutics
03/18/2010WO2010029951A1 Orally administrable formulation containing branched chain amino acid
03/18/2010WO2010029947A1 Contrast medium composition and process for producing same
03/18/2010WO2010029930A1 Stable pharmaceutical formulation with limited discoloration
03/18/2010WO2010029575A2 Docetaxel lyophilized parentaral formulation for safe drug delivery system and process of making thereof
03/18/2010WO2010029500A1 Chelating amphiphilic polymers
03/18/2010WO2010029433A1 A polysaccharide capsule enclosing a fatty acid oil-containing emulsion
03/18/2010WO2010029374A1 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
03/18/2010WO2010029159A1 Method of acylating a peptide or protein
03/18/2010WO2010028798A1 Multivalent antibodies
03/18/2010WO2010028489A1 Starch-based microparticles for the release of agents disposed therein
03/18/2010WO2010010470A3 Methods of administering topical antifungal formulations for the treatment of fungal infections
03/18/2010WO2010006392A3 Pharmaceutical composition comprising jasmonates
03/18/2010WO2009141826A3 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
03/18/2010WO2009141823A3 Conjugates of a polymer, a bisphosphonate and an anti-angiogenesis agent and uses thereof in the treatment and monitoring of bone related diseases
03/18/2010WO2009129456A4 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
03/18/2010WO2009129432A4 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
03/18/2010WO2008139313A8 Propofol transparent anaesthetic solution with low venous irritation
03/18/2010US20100069613 Implantable materials and compositions
03/18/2010US20100069571 Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith
03/18/2010US20100069512 Process for preparing an oil-in-water emulsion stabilised with recombinant collagen-like material and products prepared
03/18/2010US20100069510 Process for the manufacture of a powder containing carotenoids
03/18/2010US20100069508 Organic Compounds
03/18/2010US20100069507 Porous Carbon Materials and Production Process Thereof, and Adsorbents, Masks, Adsorbing Sheets and Carriers
03/18/2010US20100069469 Formulations and composites with reactive fillers
03/18/2010US20100069426 Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
03/18/2010US20100069397 Sexual dysfunction compounds
03/18/2010US20100069342 Formoterol/steroid bronchodilating compositions and methods of use thereof
03/18/2010US20100069293 Polymeric carrier compositions for delivery of active agents, methods of making and using the same
03/18/2010US20100069290 Ejection liquid and ejection method
03/18/2010US20100068753 Biotin-facilitated transport in gram negative bacteria
03/18/2010US20100068291 Oral Medicament Based on a Proton Pump Inhibitor
03/18/2010US20100068273 Pharmaceutical formulation, its use, and method for its manufacture
1 ... 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 ... 1712